english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

In the December issue of Prescrire International: Betibeglogene autotemcel (Zynteglo°) in certain forms of severe beta thalassaemia

Updated review of "Drugs to avoid, in the name of better patient care" is published by independent French journal Prescrire

Depression: cardiac risks with citalopram (Seropram° and other brands), even greater if combined with omeprazole (Mopral° and other brands)

Drug research: public funding, private profits

Mediator°: all wrong from the very start

Evaluation of covid-19 vaccines: the questions to ask

Doxylamine during pregnancy: minimise dose and duration, due to possible link with malformations

In the November issue of Prescrire International: Dupilumab (Dupixent°) and nasal polyps

Memory can save lives

Dapagliflozin (Forxiga°): no place in type 1 diabetes

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90